Eagle Bay Advisors LLC Abiomed Inc Transaction History

Eagle Bay Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 22, 2022	BUY	$242.49 - $301.46 $136,279 - $169,420	562 Added 244.35%	792 $196,000
Q2 2022 Aug 19, 2022	BUY	$224.73 - $338.64 $51,687 - $77,887	230 New	230 $56.9 Million
Q1 2022 May 11, 2022	SELL	$277.25 - $366.29 $63,767 - $84,246	-230 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$300.63 - $371.35 $69,144 - $85,410	-230 Reduced 50.0%	230 $83,000
Q3 2021 Nov 12, 2021	BUY	$310.19 - $376.2 $71,343 - $86,526	230 Added 100.0%	460 $150,000
Q2 2021 Jul 30, 2021	BUY	$262.71 - $351.17 $60,423 - $80,769	230 New	230 $72,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Bay Advisors LLC with notifications on news.